Research Centre:

Metro Spinal Clinic

Investigator(s):

Dr. Bruce Mitchell

Location:

Level 1,544 Hawthorn Road,Caulfield South VIC

Closer to Malvern East? There is also a research centre for this trial in Malvern East.

Purpose & Background

Metro Spinal Clinic is seeking patients with herniated intervertebral discs and persistent sciatica (back pain radiating into the lower extremity) to participate in a clinical trial. The trial medication has already been used in several hundred thousand patients, and is currently being used in Australia and other countries around the world to successfully treat conditions other than sciatic pain.

Sciatic pain occurs when one of the discs between the bones in the lower back bulges (herniates) and therefore irritates the sciatic nerve, a major nerve that provides sensation to the leg. Disc pressure on the sciatic nerve may often result in irritation, inflammation and nerve pain. Large well controlled trials have shown that most patients with sciatic pain recover without surgery over a period of two to twelve months after the onset of their pain. Since there is no approved therapy for sciatic pain during the two to twelve month natural recovery period, effective and safe treatments to reduce patients’ pain and disability during this recovery period are urgently needed.

Benefits to Participation

• The trial medication may provide sufferers with pain relief not achieved by current treatments.
• Participants will be reimbursed for their time and inconvenience caused.
• Travel expenses to and from the research unit will be reimbursed.
• Participants’ health will be monitored by qualified health professionals.
• Participants will be helping to advance medical research.

Main Eligibility Criteria

• Are aged 18 – 70
• Have had persistent and significant sciatic pain
• Do not suffer significant pain from other sources

Other Information

This trial is being conducted by medically qualified professionals, and has received ethics committee approval from the Bellberry Limited Human Research Ethics Committee. If you choose to participate, your participation will not interfere with your relationship with your normal Doctor.

What next?

If you would like to find out more information about participation in the trial, please click the link below to enter your contact details and answer some questions to determine your initial eligibility to participate in the trial. You will then be contacted by the research centre. Please note all information entered will be shared with the professional research staff at Metro Spinal Clinic, the trial sponsor, and the CMAX research organization (http://www.cmax.com.au/).

Click here to begin

Alternatively you can call 1800 656 743 between 8:30am and 6:30pm, Monday to Friday.

This study complies with the NHMRC’s National Statement on Ethical Conduct in Human Research. This study is sponsored by Bio Assets, a Biotechnology Company.

Research Centre:

Applied Science & Nutrition

Investigator(s):

Dr Elizabeth Steels

Location:

188 James St, New Farm QLD

Purpose & Background

Applied Science and Nutrition is conducting a 3-month trial investigating the effectiveness of a natural treatment for benign prostate enlargement urination symptoms.

Benefits to Participation

• The trial medication may provide sufferers with relief not achieved by current treatments.
• Participants’ health will be monitored by qualified health professionals.
• Participants will be helping to advance medical research.

Main Eligibility Criteria

• Are male aged 40 - 80
• Are diagnosed with Benign Prostatic Hyperplasia (BPH)
• Are not currently using a drug or natural therapy for BPH or other urinary symptoms

Other Information

This trial is being conducted by medically qualified professionals, and has received approval from the Australian College of Natural Medicine Human Research Ethics Committee. If you choose to participate, your participation would not be expected to interfere with your relationship with your normal doctor.

What next?

If you would like to find out more information about participation in the trial, please click the link below to enter your contact details and answer some questions to determine your initial eligibility. You will then be contacted by the research centre.

Click here to begin

If you’d like to participate, or would like to find out more information, please click the link below to enter your contact details and answer a few questions to determine your initial eligibility. You will then be contacted by the research centre. Please note all information entered is strictly confidential, and will be shared only with the research centre.

Next Step: Click here to be contacted by phone about the trial

Research Centre:

Pain Medicine Unit, Fremantle Hospital & Health Service‎

Investigator(s):

Dr Stephanie Davies

Location:

Fremantle Hospital Health Service,
Alma Street,
Fremantle, WA

Closer to Perth? There is also a research centre for this trial in Perth.

Purpose & Background

The Pain Medicine Unit (Fremantle Hospital) is seeking patients with herniated intervertebral discs and persistent sciatica (back pain radiating into the lower extremity) to participate in a clinical trial. The trial medication has already been used in several hundred thousand patients, and is currently being used in Australia and other countries around the world to successfully treat conditions other than sciatic pain.

Sciatic pain occurs when one of the discs between the bones in the lower back bulges (herniates) and therefore irritates the sciatic nerve, a major nerve that provides sensation to the leg. Disc pressure on the sciatic nerve may often result in irritation, inflammation and nerve pain. Large well controlled trials have shown that most patients with sciatic pain recover without surgery over a period of two to twelve months after the onset of their pain. Since there is no approved therapy for sciatic pain during the two to twelve month natural recovery period, effective and safe treatments to reduce patients’ pain and disability during this recovery period are urgently needed.

Benefits to Participation

• The trial medication may provide sufferers with pain relief not achieved by current treatments.
• Participants may be reimbursed for their time and inconvenience caused.
• Travel expenses to and from the research unit will be reimbursed.
• Participants’ health will be monitored by qualified health professionals.
• Participants will be helping to advance medical research.

Main Eligibility Criteria

• Are aged 18 – 70
• Have had persistent and significant sciatic pain
• Do not suffer significant pain from other sources

Other Information

This trial is being conducted by medically qualified professionals, and has received approval from the Southern Metropolitan Area Health Human Research Ethics Committee. If you choose to participate, your participation would not be expected to interfere with your relationship with your normal doctor.

What next?

If you would like to find out more information about participation in the trial, please click the link below to enter your contact details and answer some questions to determine your initial eligibility to participate in the trial. You will then be contacted by the research centre. Please note all information entered will be shared with the professional research staff at the Pain Medicine Unit, Fremantle Hospital, the trial sponsor, and the CMAX research organization (http://www.cmax.com.au/).

Click here to begin

Alternatively you can call 1800 656 743 between 8:30am and 6:30pm, Monday to Friday.

Research Centre:

Royal Newcastle Centre

Investigator(s):

Dr. Nikolai Bogduk

Location:

Royal Newcastle Centre, Lookout Road, New Lambton, NSW

Purpose & Background

The Royal Newcastle Centre is seeking patients with herniated intervertebral discs and persistent sciatica (back pain radiating into the lower extremity) to participate in a clinical trial. The trial medication has already been used in several hundred thousand patients, and is currently being used in Australia and other countries around the world to successfully treat conditions other than sciatic pain.

Sciatic pain occurs when one of the discs between the bones in the lower back bulges (herniates) and therefore irritates the sciatic nerve, a major nerve that provides sensation to the leg. Disc pressure on the sciatic nerve may often result in irritation, inflammation and nerve pain. Large well controlled trials have shown that most patients with sciatic pain recover without surgery over a period of two to twelve months after the onset of their pain. Since there is no approved therapy for sciatic pain during the two to twelve month natural recovery period, effective and safe treatments to reduce patients’ pain and disability during this recovery period are urgently needed.

Benefits to Participation

• The trial medication may provide sufferers with pain relief not achieved by current treatments.
• Participants will be reimbursed for their time and inconvenience caused.
• Travel expenses to and from the research unit will be reimbursed.
• Participants’ health will be monitored by qualified health professionals.
• Participants will be helping to advance medical research.

Main Eligibility Criteria

• Are aged 18 – 70
• Have had persistent and significant sciatic pain
• Do not suffer significant pain from other sources

Other Information

This trial is being conducted by medically qualified professionals, and has received ethics committee approval from the Hunter New England Human Research Ethics Committee. If you choose to participate, your participation will not interfere with your relationship with your normal Doctor.

What next?

If you would like to find out more information about participation in the trial, please click the link below to enter your contact details and answer some questions to determine your initial eligibility to participate in the trial. You will then be contacted by the research centre. Please note all information entered will be shared with the professional research staff at the Royal Newcastle Centre, the trial sponsor, and the CMAX research organization (http://www.cmax.com.au/).

Click here to begin

Alternatively you can call 1800 656 743 between 8:30am and 6:30pm, Monday to Friday.

This study complies with the NHMRC’s National Statement on Ethical Conduct in Human Research. This study is sponsored by BioAssets, a Biotechnology Company.

BioAssets Development Corporation, a private biotechnology company, is seeking patients with herniated intervertebral discs and persistent sciatica (back pain radiating into the lower extremity) to participate in a clinical trial. The trial medication has already been used in several hundred thousand patients, and is currently being used in Australia and other countries around the world to successfully treat conditions other than sciatic pain.

Sciatic pain occurs when one of the discs between the bones in the lower back bulges (herniates) and therefore irritates the sciatic nerve, a major nerve that provides sensation to the leg. Disc pressure on the sciatic nerve may often result in irritation, inflammation and nerve pain. Large well controlled trials have shown that most patients with sciatic pain recover without surgery over a period of two to twelve months after the onset of their pain. Since there is no approved therapy for sciatic pain during the two to twelve month natural recovery period, effective and safe treatments to reduce patients’ pain and disability during this recovery period are urgently needed.

Benefits to Participation

• The trial medication may provide sufferers with pain relief not achieved by current treatments.
• Participants will have prompt access to a medical consultation.
• Participants will be reimbursed for their time and inconvenience caused.
• Travel expenses to and from the research unit will be reimbursed.
• Participants’ health will be monitored by qualified health professionals.
• Participants will be helping to advance medical research.

Main Eligibility Criteria

• Are aged 18 – 70
• Have had persistent and significant sciatic pain
• Do not suffer significant pain from other sources

What next?

If you would like to find out more information about participation in the trial, please click the link below to enter your contact details and answer some questions to determine your eligibility to participate in the trial. If you are eligible for the trial, you will be contacted by a study coordinator.

BioAssets expects to open a clinical site at a major hospital in Sydney in the near future and will notify eligible individuals when the clinical site opens.

Please note all information entered will be shared with the professional research staff at the clinical site, the trial sponsor, and the CMAX research organization (http://www.cmax.com.au/).

Click here to begin

Alternatively you can call 1800 656 743 between 8:30am and 6:30pm, Monday to Friday.

This study complies with the NHMRC’s National Statement on Ethical Conduct in Human Research. This study is sponsored by BioAssets, a Biotechnology Company.

Research Centre:

Emeritus Research

Investigator(s):

Dr. Stephen Hall

Location:

291 Wattletree Rd,Malvern East, VIC

Closer to Caulfield South? There is also a research centre for this trial in Caulfield South.

Purpose & Background

Emeritus Research is seeking patients with herniated intervertebral discs and persistent sciatica (back pain radiating into the lower extremity) to participate in a clinical trial. The trial medication has already been used in several hundred thousand patients, and is currently being used in Australia and other countries around the world to successfully treat conditions other than sciatic pain.

Sciatic pain occurs when one of the discs between the bones in the lower back bulges (herniates) and therefore irritates the sciatic nerve, a major nerve that provides sensation to the leg. Disc pressure on the sciatic nerve may often result in irritation, inflammation and nerve pain. Large well controlled trials have shown that most patients with sciatic pain recover without surgery over a period of two to twelve months after the onset of their pain. Since there is no approved therapy for sciatic pain during the two to twelve month natural recovery period, effective and safe treatments to reduce patients’ pain and disability during this recovery period are urgently needed.

Benefits to Participation

• The trial medication may provide sufferers with pain relief not achieved by current treatments.
• Participants will be reimbursed for their time and inconvenience caused.
• Travel expenses to and from the research unit will be reimbursed.
• Participants’ health will be monitored by qualified health professionals.
• Participants will be helping to advance medical research.

Main Eligibility Criteria

• Are aged 18 – 70
• Have had persistent and significant sciatic pain
• Do not suffer significant pain from other sources

Other Information

This trial is being conducted by medically qualified professionals, and has received ethics committee approval from the Bellberry Limited Human Research Ethics Committee. If you choose to participate, your participation will not interfere with your relationship with your normal Doctor.

What next?

If you would like to find out more information about participation in the trial, please click the link below to enter your contact details and answer some questions to determine your initial eligibility to participate in the trial. You will then be contacted by the research centre. Please note all information entered will be shared with the professional research staff at Emeritus Research, the trial sponsor, and the CMAX research organization (http://www.cmax.com.au/).

Click here to begin

Alternatively you can call 1800 656 743 between 8:30am and 6:30pm, Monday to Friday.

This study complies with the NHMRC’s National Statement on Ethical Conduct in Human Research. This study is sponsored by Bio Assets, a Biotechnology Company.

WANTED

Healthy male volunteers

To participate in a short study of a new treatment for anxiety.

If you are aged between 18 - 65 years

We'd like to hear from you!

• You must be willing to sleep over (2 days, 2 nights)
• You will be reimbursed

If you would like to find out more please fill out the questionnaire by clicking the link below

This study is approved by the Royal Adelaide Hospital Research Ethics Committee

Research Centre:

Department of Pain Management

Investigator(s):

Dr Roger Goucke

Location:

Sir Charles Gairdner Hospital,
Hospital Avenue,
Nedlands, Perth

Closer to Fremantle? There is also a research centre for this trial in Fremantle.

Purpose & Background

The Department of Pain Management (SCGH) is seeking patients with herniated intervertebral discs and persistent sciatica (back pain radiating into the lower extremity) to participate in a clinical trial. The trial medication has already been used in several hundred thousand patients, and is currently being used in Australia and other countries around the world to successfully treat conditions other than sciatic pain.

Sciatic pain occurs when one of the discs between the bones in the lower back bulges (herniates) and therefore irritates the sciatic nerve, a major nerve that provides sensation to the leg. Disc pressure on the sciatic nerve may often result in irritation, inflammation and nerve pain. Large well controlled trials have shown that most patients with sciatic pain recover without surgery over a period of two to twelve months after the onset of their pain. Since there is no approved therapy for sciatic pain during the two to twelve month natural recovery period, effective and safe treatments to reduce patients’ pain and disability during this recovery period are urgently needed.

Benefits to Participation

• The trial medication may provide sufferers with pain relief not achieved by current treatments.
• Participants will be reimbursed for their time and inconvenience caused.
• Travel expenses to and from the research unit will be reimbursed.
• Participants’ health will be monitored by qualified health professionals.
• Participants will be helping to advance medical research.

Main Eligibility Criteria

• Are aged 18 – 70
• Have had persistent and significant sciatic pain
• Do not suffer significant pain from other sources

Other Information

This trial is being conducted by medically qualified professionals, and has received approval from the Sir Charles Gairdner Hospital Human Research Ethics Committee. If you choose to participate, your participation would not be expected to interfere with your relationship with your normal doctor.

What next?

If you would like to find out more information about participation in the trial, please click the link below to enter your contact details and answer some questions to determine your initial eligibility to participate in the trial. You will then be contacted by the research centre. Please note all information entered will be shared with the professional research staff at the Department of Pain Management, Sir Charles Gairdner Hospital, the trial sponsor, and the CMAX research organization (http://www.cmax.com.au/).

Click here to begin

Alternatively you can call 1800 656 743 between 8:30am and 6:30pm, Monday to Friday.

Applied Science and Nutrition is conducting a 12-month trial investigating the effectiveness of a topical Manuka oil cream for the treatment of cold sores.

You may be eligible if you:
• are over 18 years of age
• experience two or more cold sores per year
• can attend a Brisbane clinic at the start of each cold sore episode
• do not have any major illness

The study has been approved by the Australian College of Natural Medicine Human Research Ethics Committee and the interviews will be held at the Applied Science and Nutrition clinics located in New Farm.

To register your interest, please contact the research group either by phoning 3162 0909 (between 9-3pm Mon-Fri), or by completing the short questionnaire below.

This study is peer-reviewed by a scientific advisory committee and conducted in accordance with International and Australian guidelines for clinical research under the approval of the Queensland Clinical Trial Network Human Research Ethics Committee. We respect your privacy and will not use your details for any purpose other than described.

Research Centre:

The Pain & Anaesthesia Research Clinic (PARC)

Investigator(s):

Dr. Guy Ludbrook

Location:

Royal Adelaide Hospital, North Terrace, Adelaide South Australia

Purpose & Background

The Pain & Anaesthesia Research Clinic (PARC) is seeking patients with sciatic (lower back) pain to participate in a clinical trial. The trial medication has already been used in several hundred thousand patients, and is currently being used in Australia and other countries around the world to successfully treat conditions other than sciatic pain.

Sciatic pain occurs when one of the discs between the bones in the lower back bulges (herniates) and therefore irritates the sciatic nerve, a major nerve that provides sensation to the leg. Disc pressure on the sciatic nerve may often result in irritation, inflammation and nerve pain. The pain results in a burning sensation which extends from the lower back down one or both legs. Large well controlled trials have shown that most patients with sciatic pain recover without surgery over a period of two to twelve months after the onset of their pain. Since there is no approved therapy for sciatic pain during the two to twelve month natural recovery period, effective and safe treatments to reduce patients’ pain and disability during this recovery period are urgently needed.

Benefits to Participation

• The trial medication may provide sufferers with pain relief not achieved by current treatments.
• Participants will be reimbursed for their time and inconvenience caused.
• Travel expenses to and from the research unit will be reimbursed.
• Participants’ health will be monitored by qualified health professionals.
• Participants will be helping to advance medical research.

Main Eligibility Criteria

• Are aged 18 – 70
• Have had persistent and significant sciatic pain for less than six months
• Do not suffer significant pain from other sources

Other Information

This trial is being conducted by medically qualified professionals, and has received ethics committee approval from the Royal Adelaide Hospital Human Research Ethics Committee. If you choose to participate, your participation will not interfere with your relationship with your normal Doctor.

What next?

If you would like to find out more information about participation in the trial, please click the link below to enter your contact details and answer some questions to determine your initial eligibility to participate in the trial. You will then be contacted by the research centre. Please note all information entered is strictly confidential, and will be shared only with The Pain & Anaesthesia Research Clinic (PARC).

Alternatively you can call 1800 656 743 between 8:30am and 6:30pm, Monday to Friday. Please note the call centre will be closed for the Christmas break until Jan 11th.

Research Centre:

The Australian Cerebral Palsy Research Group (ACPRG)

Investigator(s):

Professor Alastair MacLennan
Dr Catherine Gibson
A/Prof Paul Goldwater

Location:

This trial is being conducted throughout all of Australia.

Purpose & Background

The Australian Cerebral Palsy Research Group (ACPRG) is seeking children and their mothers to participate in a clinical trial. ACPRG requires volunteers from two different groups:

• Children who have been diagnosed with cerebral palsy.
• Children who do not have cerebral palsy.

1 in 500 babies born in Australia are diagnosed with cerebral palsy. People with cerebral palsy lack control of their movement and posture as a result of brain injury in the motor control region. The symptoms vary greatly in severity, ranging from poor muscle co-ordination to quadriplegia, and there is currently no cure.

Previous studies have shown a link between human genetics and cerebral palsy, however stronger family based evidence is now required. Participation is non-invasive and can be conducted in your own home. It only requires a swab of the inside of the participating child’s and mother’s cheek and completion of a short questionnaire by the child’s mother.

Benefits to Participation

• This is the largest study of its type worldwide and has the potential to make a major contribution to our current knowledge of cerebral palsy. Your participation may help to unlock some of the mystery surrounding this condition and how we can reduce its incidence in future generations.
• No clinic visit or invasive procedures are required - a simple swab to the inside of the child’s and mother’s cheek is all that is needed.

Main Eligibility Criteria

• Caucasian children aged 5 – 18 who have been diagnosed with cerebral palsy.
• Caucasian children aged 5 – 18 who do not have cerebral palsy.
• The child’s mother will also be required to provide a cheek swab and complete a short questionnaire.
• Children must have been born in Australia.

Other Information

This trial is being conducted by medically qualified professionals, and has received ethics committee approval from the Adelaide Children, Youth and Women’s Health Service Human Research Ethics Committee. If you choose to participate, your participation will not interfere with your relationship with your normal Doctor.

What next?

If you’d like to participate, or would like to find out more information, please click the link below to enter your contact details and answer a few questions to determine your initial eligibility. You will then be contacted by the research centre. Please note all information entered is strictly confidential, and will be shared only with The Australian Cerebral Palsy Research Group.

If you have a relative with type 1 diabetes we need your help in developing a type 1 diabetes vaccine.

A simple test will determine whether you have a predisposition to type 1 diabetes. If you are at a high risk of developing type 1 diabetes the trial treatment may prevent you from developing the condition. Your participation could play a crucial role in the prevention of type 1 diabetes in your children or grandchildren and aid in the development of a type 1 diabetes vaccine.

To be eligible you must:
• be between the ages of 4 and 30
• have a 1st degree relative (mother, father, brother, sister) or 2nd degree relative (grandparent, uncle, aunt, half brother, half sister) with type 1 diabetes.

All medical care, examinations, tests and the study medication are provided free of charge, and travel expenses will be reimbursed.

The trial is being conducted by medically qualified professionals, and has received ethics committee approval from the Children, Youth & Women's HealthService Human Research Ethics Committees. If you choose to participate, your participation will not interfere with your relationship with your regular Doctor. Please note the call centre will be closed for the Christmas break until Jan 11th.

Research Centres:

The Pain & Anaesthesia Research Clinic (PARC)

Emeritus Research

Department of Pain Management, Sir Charles Gairdner Hospital

Investigator(s):

Dr. Guy Ludbrook

Dr. Stephen Hall

Dr. Roger Goucke

Location:

Purpose & Background

The Pain & Anaesthesia Research Clinic (PARC) is seeking patients with herniated intervertebral discs and persistent sciatica (back pain radiating into the lower extremity) to participate in a clinical trial. The trial medication has already been used in several hundred thousand patients, and is currently being used in Australia and other countries around the world to successfully treat conditions other than sciatic pain.

Sciatic pain occurs when one of the discs between the bones in the lower back bulges (herniates) and therefore irritates the sciatic nerve, a major nerve that provides sensation to the leg. Disc pressure on the sciatic nerve may often result in irritation, inflammation and nerve pain. Large well controlled trials have shown that most patients with sciatic pain recover without surgery over a period of two to twelve months after the onset of their pain. Since there is no approved therapy for sciatic pain during the two to twelve month natural recovery period, effective and safe treatments to reduce patients’ pain and disability during this recovery period are urgently needed.

Benefits to Participation

• The trial medication may provide sufferers with pain relief not achieved by current treatments.
• Participants will be reimbursed for their time and inconvenience caused.
• Travel expenses to and from the research unit will be reimbursed.
• Participants’ health will be monitored by qualified health professionals.
• Participants will be helping to advance medical research.

Main Eligibility Criteria

• Are aged 18 – 70
• Have had persistent and significant sciatic pain
• Do not suffer significant pain from other sources

Other Information

This trial is being conducted by medically qualified professionals, and has received ethics committee approval from the Royal Adelaide Hospital Human Research Ethics Committee. If you choose to participate, your participation will not interfere with your relationship with your normal Doctor.

What next?

If you would like to find out more information about participation in the trial, please click the link below to enter your contact details and answer some questions to determine your initial eligibility to participate in the trial. You will then be contacted by the research centre. Please note all information entered will be shared with the professional research staff at the Pain & Anaesthesia Research Clinic (PARC), the trial sponsor, and the CMAX research organization (http://www.cmax.com.au/).

Research Centre:

The Pain & Anaesthesia Research Clinic (PARC)

Investigator(s):

Dr. Guy Ludbrook

Location:

Royal Adelaide Hospital, North Terrace, Adelaide South Australia

Purpose & Background

The Pain & Anaesthesia Research Clinic (PARC) is seeking patients with herniated intervertebral discs and persistent sciatica (back pain radiating into the lower extremity) to participate in a clinical trial. The trial medication has already been used in several hundred thousand patients, and is currently being used in Australia and other countries around the world to successfully treat conditions other than sciatic pain.

Sciatic pain occurs when one of the discs between the bones in the lower back bulges (herniates) and therefore irritates the sciatic nerve, a major nerve that provides sensation to the leg. Disc pressure on the sciatic nerve may often result in irritation, inflammation and nerve pain. Large well controlled trials have shown that most patients with sciatic pain recover without surgery over a period of two to twelve months after the onset of their pain. Since there is no approved therapy for sciatic pain during the two to twelve month natural recovery period, effective and safe treatments to reduce patients’ pain and disability during this recovery period are urgently needed.

Benefits to Participation

• The trial medication may provide sufferers with pain relief not achieved by current treatments.
• Participants will be reimbursed for their time and inconvenience caused.
• Travel expenses to and from the research unit will be reimbursed.
• Participants’ health will be monitored by qualified health professionals.
• Participants will be helping to advance medical research.

Main Eligibility Criteria

• Are aged 18 – 70
• Have had persistent and significant sciatic pain
• Do not suffer significant pain from other sources

Other Information

This trial is being conducted by medically qualified professionals, and has received ethics committee approval from the Royal Adelaide Hospital Human Research Ethics Committee. If you choose to participate, your participation will not interfere with your relationship with your normal Doctor.

What next?

If you would like to find out more information about participation in the trial, please click the link below to enter your contact details and answer some questions to determine your initial eligibility to participate in the trial. You will then be contacted by the research centre. Please note all information entered will be shared with the professional research staff at the Pain & Anaesthesia Research Clinic (PARC), the trial sponsor, and the CMAX research organization (http://www.cmax.com.au/).

Click here to begin

Alternatively you can call 1800 656 743 between 8:30am and 6:30pm, Monday to Friday.